Medication Guide - 2/26/2021

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Thalomid Thalidomide CAPSULE;ORAL 020785 CELGENE 02/25/2021 Ampyra Dalfampridine TABLET, EXTENDED RELEASE;ORAL 022250 ACORDA 02/24/2021 Humira Adalimumab SYRINGE 125057 ABBVIE INC 02/24/2021 Humira Adalimumab VIAL 125057 ABBVIE INC 02/24/2021 Hyrimoz Adalimumab-Adaz INJECTABLE;INJECTION 761071 SANDOZ INC 02/24/2021 Libtayo Cemiplimab-Rwlc INJECTABLE;INTRAVENOUS 761097 REGENERON PHARMACEUTICALS 02/22/2021 Singulair Montelukast Sodium TABLET;ORAL 020829 MSD MERCK CO 02/22/2021 Imfinzi Durvalumab INJECTABLE;INJECTION 761069 ASTRAZENECA UK LTD 02/19/2021 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA